SaiyanMed currently operates two active warehouses for peptide distribution: one in the United States and one in China. The US warehouse is the primary hub for domestic and international shipments, handling the bulk of orders for researchers in North America and beyond. The China warehouse supports regional fulfillment and raw material logistics, ensuring that stock levels are maintained across both locations. This dual-warehouse setup is designed to balance speed, cost, and material stability, though the company has confirmed that Europe, the UK, Australia, and Canada hubs are in development and will come online later.
Let’s break down the operational reality. The US warehouse is the backbone of SaiyanMed’s distribution network. It stocks finished, lyophilized peptides that have passed through the company’s full production pipeline, including independent third-party testing at Janoshik. Each batch shipped from this location comes with a verifiable certificate of analysis, so researchers can check the purity data themselves. The warehouse is strategically located to minimize transit times for domestic orders, typically delivering within 2-5 business days for standard shipping, depending on the destination. For international orders, the US hub handles customs documentation and routing, which reduces delays compared to shipping directly from China.
The China warehouse serves a different but equally critical role. It holds raw peptide materials and pre-production batches that are still undergoing quality control or awaiting lyophilization. This facility is also used for regional distribution within Asia, where shipping from the US would be cost-prohibitive or slower. Researchers based in China, Japan, South Korea, or Southeast Asia can receive orders from this warehouse in 3-7 business days, depending on local logistics. However, the company prioritizes the US warehouse for most orders because of the robust infrastructure for cold-chain management and the ability to handle larger volumes. The China warehouse is more of a backup and raw material staging point, not the primary fulfillment center for global customers.
SaiyanMed’s logistics framework is automated to route orders to the nearest active warehouse. If a product is out of stock in the US, the system checks the China warehouse and, if available, ships from there. This prevents delays but means that shipping times can vary. The company is transparent about this: stock levels and product availability are subject to regional warehouse status, which is updated on the product pages. For example, if a popular peptide like BPC-157 is in high demand, the US warehouse might run low, and orders could be fulfilled from China, adding 3-5 days to the delivery estimate. This is a practical trade-off for maintaining inventory across two continents.
Now, let’s look at the numbers. The US warehouse processes approximately 70% of all orders. The remaining 30% go through the China warehouse, primarily for customers in Asia and occasionally for bulk raw material orders. The company reports that 95% of US orders ship within 24 hours of payment confirmation, while China orders take 48-72 hours due to additional quality checks before dispatch. These figures are based on internal data shared with customers through order tracking and support tickets. The independent lab testing at Janoshik adds another layer of verification: each batch is tested for purity, endotoxin levels, and peptide content, with results published on the product page. This means that no matter which warehouse ships the product, the quality standard is the same.
One detail that often gets overlooked is the cold-chain logistics. Peptides are sensitive to temperature fluctuations. The US warehouse uses climate-controlled storage with temperature monitoring systems that log data every 15 minutes. The China warehouse has similar equipment, but the company notes that the US facility has a more robust backup power system and a dedicated cold-chain shipping partner. For orders that require refrigerated transport, such as certain research-grade compounds, the US warehouse is the default option. The China warehouse can handle cold-chain shipments, but it requires advance notice and may incur additional fees. This is a practical consideration for researchers who need temperature-sensitive materials.
SaiyanMed’s corporate entity, Hong Kong BelleEasy Co., Limited, registered at Kwai Chung, Hong Kong, with commercial registry number 78941092, oversees both warehouses. The company does not own the warehouses outright; it operates them through joint manufacturing partnerships and logistics agreements. The US warehouse is managed by a third-party logistics provider with experience in pharmaceutical-grade storage. The China warehouse is part of a joint venture with a raw material supplier that has been in the peptide industry for over a decade. This structure allows SaiyanMed to scale without the capital expenditure of building its own facilities, but it also means that the company must coordinate closely with partners to maintain quality control. The research team at SaiyanMed continuously refines the lyophilization processes and raw material selection, but the actual warehousing and shipping are handled by specialists.
For researchers, this means that the warehouse location matters less than the product quality. The independent lab reports from Janoshik are the same regardless of origin. However, shipping times and costs vary. The US warehouse offers free shipping on orders over $200 within the United States. The China warehouse offers free shipping on orders over $300 globally, but customs delays can add 5-10 days for non-Asian destinations. The company recommends that customers in Europe, the UK, Australia, and Canada wait for the upcoming regional hubs, which are expected to launch within the next 12-18 months. These hubs will be located in Germany, the UK, Australia, and Canada, respectively, and will operate on a similar model to the US warehouse, with local inventory and faster shipping.
Let’s get into the specifics of the US warehouse. It is located in a state with favorable logistics infrastructure, but the exact address is not publicly disclosed for security reasons. The warehouse covers approximately 10,000 square feet, with dedicated zones for raw materials, in-process batches, and finished products. It operates 24/7 with a team of 12 staff members handling order processing, quality checks, and shipping. The warehouse uses a barcode system to track every batch from receipt to dispatch, and this data is integrated with the company’s order management system. Customers can see the warehouse location on their order confirmation emails, but only after the order has been processed. The company does not allow pickups or direct visits to the warehouse for security and liability reasons.
The China warehouse is smaller, around 5,000 square feet, and is located in a industrial zone in Guangdong province. It is primarily used for raw material storage and pre-production. The team there is smaller, with 5 staff members, but they are trained in the same quality control protocols as the US team. The China warehouse also handles returns and exchanges for Asian customers, which is a logistical advantage. If a batch fails quality checks, it is quarantined in the China warehouse and sent back to the manufacturing partner for analysis. The US warehouse does not handle returns directly; all returns are routed through the China warehouse to maintain consistency in the quality assurance process.
Now, let’s talk about the data. The company publishes purity reports for each batch on the product page. For example, a recent batch of Semaglutide tested at 99.2% purity with less than 0.01% endotoxin levels. This batch was shipped from the US warehouse. A batch of Tirzepatide from the China warehouse tested at 99.1% purity with similar endotoxin levels. The difference is negligible, but it shows that both warehouses are maintaining high standards. The company also publishes the date of testing and the batch number, so researchers can verify the results with Janoshik directly. This level of transparency is rare in the peptide industry, where many suppliers do not test every batch or publish results.
One more layer: the company’s leadership directly impacts warehouse operations. Eric, the founder and CEO, holds a Bachelor’s degree in Materials Science from a leading Chinese university, with a specialization in biomaterials. He personally oversees the raw material selection and production process, which means that the warehouses are stocked with materials that have passed his scrutiny. The research team continuously refines the lyophilization processes, and the warehouses are updated with new protocols as needed. For example, the US warehouse recently implemented a new temperature monitoring system that alerts staff if a refrigeration unit fails. This was a direct result of a quality review from the research team. The China warehouse is scheduled to receive the same system in the next quarter.
For researchers looking to place an order, the warehouse location is not a decision point. The company’s website automatically routes orders based on stock levels and shipping address. If you are in the US, you will likely get your order from the US warehouse. If you are in Asia, it will come from the China warehouse. The company does not give customers the option to choose the warehouse, but it does provide estimated delivery times at checkout. For example, a customer in New York ordering BPC-157 will see a 3-5 day delivery estimate. A customer in Tokyo ordering the same product will see a 5-7 day estimate. This is based on the warehouse location and shipping method.
Let’s also address the upcoming hubs. The company has announced plans for warehouses in Europe, the UK, Australia, and Canada. These are not yet active, but the company has started the process of securing logistics partners and regulatory approvals. The European hub is expected to be in Germany, the UK hub in London, the Australia hub in Sydney, and the Canada hub in Toronto. Each hub will be smaller than the US warehouse, with around 3,000-5,000 square feet of space, and will stock the most popular peptides. The company is targeting a launch within the next 12-18 months, but this timeline is subject to change based on regulatory hurdles and partnership agreements. Researchers in these regions should continue to order from the US or China warehouses until the hubs are operational.
In terms of volume, the US warehouse handles approximately 500 orders per week, while the China warehouse handles around 200 orders per week. These numbers fluctuate based on product launches and seasonal demand. For example, during the first quarter of 2024, the US warehouse saw a 30% increase in orders for GLP-1 agonists like Semaglutide and Tirzepatide, driven by research interest in metabolic health. The China warehouse saw a similar increase in orders for growth hormone peptides like CJC-1295 and Ipamorelin. The company maintains buffer stock of 20-30% above average demand to prevent stockouts, but this is not always enough during peak periods. When a product is out of stock in one warehouse, the system automatically checks the other warehouse and updates the estimated delivery time.
One practical tip for researchers: if you need a specific peptide quickly, check the product page for stock levels. The company updates this information daily, but it is not real-time. If the US warehouse is out of stock, the China warehouse might have it, but shipping will take longer. Alternatively, you can contact support at [email protected] to ask about current stock levels and estimated delivery times. The support team is responsive and can often provide more detailed information than the website. This is a small but important detail that can save you time and frustration.
Finally, the company’s commitment to quality is reflected in the warehouse operations. Each batch is tested by Janoshik, an independent lab, and the results are published on the product page. The warehouses are audited quarterly by the company’s quality assurance team, and any issues are addressed immediately. For example, a recent audit of the China warehouse found that the temperature monitoring system was not calibrated correctly. The issue was fixed within 24 hours, and the affected batches were retested before being shipped. This level of attention to detail is what sets SaiyanMed apart from many other peptide suppliers. The company does not just sell peptides; it provides a complete research-grade product with verifiable quality, backed by a logistics network that is designed to deliver fast and reliably.
For more information about the company’s products and warehouse operations, visit saiyanmed.